27334

    544293

    SURAKSHA

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    SURAKSHA DIAGNOSTIC LTD Share Price Today

    SURAKSHA DIAGNOSTIC LTD is currently trading at ₹258.8, down by ₹1.1 from the previous close. The stock touched an intraday high of ₹261.40 and a low of ₹257.00 during the latest trading session. Over the past one year, SURAKSHA DIAGNOSTIC LTD has delivered a loss of 17.82%, while the stock has declined 2.55% in the last one month.

    SURAKSHA DIAGNOSTIC LTD performance

    Today’s low Today’s high
    ₹ 257.00 ₹ 261.40
    ₹ 258.80
    52 week low 52 week high
    ₹ 224.10 ₹ 333.00
    ₹ 258.80
    Open Price ₹ 261.40
    Prev. Close ₹ 259.90
    Volume (Shares) 6991.00
    Total traded value ₹ 18.09
    Upper Circuit ₹ 311.85
    Lower Circuit ₹ 207.95
    info

    Investment Returns

    Over 1 Month -2.55% Over 3 Months -6.65% Over 6 Months -1.58% Over 1 Year -17.82%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    SURAKSHA DIAGNOSTIC LTD fundamentals


    • Market cap (Cr) 1,347.90
    • P/E Ratio (TTM) 39.76
    • Beta 0.52
    • Book Value / share 47.96
    • Return on equity 16.99%
    • EPS (TTM) 6.54
    • Dividend yield 0.19%
    • Net profit/quarter (Cr) 6.71
    info icon alternate text
    • Market cap (Cr) 1,354.10
    • P/E Ratio (TTM) 39.76
    • Beta 0.46
    • Book Value / share 47.96
    • Return on equity 16.99%
    • EPS (TTM) 6.54
    • Dividend yield 0.19%
    • Net profit/quarter (Cr) 6.71
    info icon alternate text

    SURAKSHA DIAGNOSTIC LTD Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 78.56
    Operating Expense 69.31
    Net Profit 6.71
    Net Profit Margin (%) 8.54
    Earnings Per Share (EPS) 1.29
    EBITDA 25.11
    Effective Tax Rate (%) 36.45
    Particulars DEC 2025 (Values in Cr)
    Revenue 75.58
    Operating Expense 65.60
    Net Profit 8.14
    Net Profit Margin (%) 10.77
    Earnings Per Share (EPS) 1.56
    EBITDA 24.18
    Effective Tax Rate (%) 25.79
    Particulars SEP 2025 (Values in Cr)
    Revenue 76.26
    Operating Expense 64.66
    Net Profit 9.36
    Net Profit Margin (%) 12.27
    Earnings Per Share (EPS) 1.80
    EBITDA 24.94
    Effective Tax Rate (%) 25.53
    Particulars JUN 2025 (Values in Cr)
    Revenue 70.28
    Operating Expense 58.26
    Net Profit 9.85
    Net Profit Margin (%) 14.01
    Earnings Per Share (EPS) 1.89
    EBITDA 24.93
    Effective Tax Rate (%) 24.92
    Particulars MAR 2025 (Values in Cr)
    Revenue 64.15
    Operating Expense 55.04
    Net Profit 8.01
    Net Profit Margin (%) 12.48
    Earnings Per Share (EPS) 1.54
    EBITDA 20.75
    Effective Tax Rate (%) 20.21
    Particulars MAR 2026 (Values in Cr)
    Revenue 300.68
    Operating Expense 257.82
    Net Profit 34.06
    Net Profit Margin (%) 11.32
    Earnings Per Share (EPS) 6.54
    EBITDA 99.16
    Effective Tax Rate (%) 27.84
    Particulars MAR 2025 (Values in Cr)
    Revenue 249.10
    Operating Expense 209.62
    Net Profit 33.44
    Net Profit Margin (%) 13.42
    Earnings Per Share (EPS) 6.42
    EBITDA 86.97
    Effective Tax Rate (%) 23.75
    Particulars MAR 2024 (Values in Cr)
    Revenue 218.52
    Operating Expense 188.69
    Net Profit 24.38
    Net Profit Margin (%) 11.15
    Earnings Per Share (EPS) 7.06
    EBITDA 74.07
    Effective Tax Rate (%) 25.43
    Particulars MAR 2023 (Values in Cr)
    Revenue 189.99
    Operating Expense 185.69
    Net Profit 7.19
    Net Profit Margin (%) 3.78
    Earnings Per Share (EPS) 2.08
    EBITDA 48.56
    Effective Tax Rate (%) 8.64
    Particulars MAR 2022 (Values in Cr)
    Revenue 223.19
    Operating Expense 192.31
    Net Profit 23.75
    Net Profit Margin (%) 10.64
    Earnings Per Share (EPS) 344.00
    EBITDA 49.81
    Effective Tax Rate (%) 28.44
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 40.56
    ROE % 15.93
    ROCE % 17.66
    Total Debt to Total Equity 0.46
    EBITDA Margin 34.02
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 257.65
    ROE % 13.93
    ROCE % 15.67
    Total Debt to Total Equity 0.56
    EBITDA Margin 33.67
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 223.62
    ROE % 4.78
    ROCE % 8.87
    Total Debt to Total Equity 0.38
    EBITDA Margin 26.51
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 2149.92
    ROE % 17.40
    ROCE % 22.62
    Total Debt to Total Equity 0.13
    EBITDA Margin 22.57
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 1805.72
    ROE % 6.70
    ROCE % 7.61
    Total Debt to Total Equity 0.11
    EBITDA Margin 18.67
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 41.15
    ROE % 16.99
    ROCE % 18.36
    Total Debt to Total Equity 0.45
    EBITDA Margin 35.18
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 259.76
    ROE % 14.59
    ROCE % 16.07
    Total Debt to Total Equity 0.56
    EBITDA Margin 34.25
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 224.63
    ROE % 5.62
    ROCE % 9.38
    Total Debt to Total Equity 0.38
    EBITDA Margin 27.11
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 2150.51
    ROE % 17.40
    ROCE % 22.61
    Total Debt to Total Equity 0.13
    EBITDA Margin 22.58
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 1806.30
    ROE % 6.72
    ROCE % 7.64
    Total Debt to Total Equity 0.11
    EBITDA Margin 18.70
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 20.10
    Total Assets 333.52
    Total Liabilities 333.52
    Total Equity 210.23
    Share Outstanding 5
    Price to Book Ratio 6.26
    Return on Assets (%) 9.54
    Return on Capital (%) 14.73
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 55.02
    Total Assets 300.20
    Total Liabilities 300.20
    Total Equity 179.14
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 7.86
    Return on Capital (%) 12.58
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 55.03
    Total Assets 281.19
    Total Liabilities 281.19
    Total Equity 155.46
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 2.31
    Return on Capital (%) 3.85
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 2.82
    Total Assets 200.71
    Total Liabilities 200.71
    Total Equity 149.97
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 11.83
    Return on Capital (%) 14.05
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 4.43
    Total Assets 171.04
    Total Liabilities 171.04
    Total Equity 126.22
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 3.76
    Return on Capital (%) 4.51
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 15.52
    Total Assets 333.10
    Total Liabilities 333.10
    Total Equity 214.31
    Share Outstanding 5
    Price to Book Ratio 6.26
    Return on Assets (%) 10.03
    Return on Capital (%) 15.19
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 52.80
    Total Assets 301.74
    Total Liabilities 301.74
    Total Equity 180.86
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 8.08
    Return on Capital (%) 12.87
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 54.62
    Total Assets 282.05
    Total Liabilities 282.05
    Total Equity 156.62
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 2.54
    Return on Capital (%) 4.21
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 45.13
    Total Assets 283.87
    Total Liabilities 283.87
    Total Equity 149.42
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 8.36
    Return on Capital (%) 14.1
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 4.35
    Total Assets 171.07
    Total Liabilities 171.07
    Total Equity 126.26
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 3.78
    Return on Capital (%) 4.54
    Particulars MAR 2025 (Values in Cr)
    Net Income 41.40
    Cash from Operations 73.94
    Cash from Investing -39.58
    Cash from Financing -24.04
    Net change in Cash -0.27
    Free Cash Flow 115.96
    Particulars MAR 2024 (Values in Cr)
    Net Income 31.45
    Cash from Operations 69.09
    Cash from Investing -34.99
    Cash from Financing -25.12
    Net change in Cash 0.35
    Free Cash Flow 114.56
    Particulars MAR 2023 (Values in Cr)
    Net Income 6.74
    Cash from Operations 51.29
    Cash from Investing -20.79
    Cash from Financing -24.32
    Net change in Cash -1.02
    Free Cash Flow 64.45
    Particulars MAR 2022 (Values in Cr)
    Net Income 33.19
    Cash from Operations 48.58
    Cash from Investing -43.78
    Cash from Financing 1.08
    Net change in Cash -0.35
    Free Cash Flow 67.83
    Particulars MAR 2021 (Values in Cr)
    Net Income 6.37
    Cash from Operations 25.61
    Cash from Investing -27.70
    Cash from Financing 3.21
    Net change in Cash -0.98
    Free Cash Flow 41.01
    Particulars MAR 2025 (Values in Cr)
    Net Income 43.85
    Cash from Operations 73.37
    Cash from Investing -39.28
    Cash from Financing -24.14
    Net change in Cash -0.63
    Free Cash Flow 108.76
    Particulars MAR 2024 (Values in Cr)
    Net Income 32.70
    Cash from Operations 69.82
    Cash from Investing -35.03
    Cash from Financing -25.83
    Net change in Cash 0.36
    Free Cash Flow 112.04
    Particulars MAR 2023 (Values in Cr)
    Net Income 7.87
    Cash from Operations 52.11
    Cash from Investing -22.04
    Cash from Financing -24.32
    Net change in Cash -1.44
    Free Cash Flow 65.22
    Particulars MAR 2022 (Values in Cr)
    Net Income 33.19
    Cash from Operations 46.76
    Cash from Investing -43.69
    Cash from Financing 1.08
    Net change in Cash -0.27
    Free Cash Flow 65.87
    Particulars MAR 2021 (Values in Cr)
    Net Income 6.41
    Cash from Operations 25.64
    Cash from Investing -27.71
    Cash from Financing 3.21
    Net change in Cash -0.96
    Free Cash Flow 44.40
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTER. L 8933.85 65.67 13.56 128455.06 6680.00 9008.90
    FORTIS MALAR HOSPITALS LIMITED 50.36 22.79 2.74 94.38 40.75 76.00
    SHREE PACETRONIX LTD. 150.70 17.98 3.17 56.51 71.00 283.15
    TRANSGENE BIOTEK LTD. 3.16 0.00 2.85 23.94 1.83 5.26
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTER. L 8933.85 85.57 12.89 128455.06 6680.00 9008.90
    [-] 0.0 0.0 0.0 0.0 0.0 0.0
    CHENNAI MEENAKSHI MULTISPECIAL 38.52 0.00 -9.37 28.77 30.30 57.48
    KOVAI MEDICAL CENTER & HO 5976.95 26.75 4.95 6538.78 5010.00 6725.00

    SURAKSHA DIAGNOSTIC LTD shareholding pattern

    Holding
    14.3%
    49.09%
    13.45%
    23.13%
    0.1%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    SURAKSHA DIAGNOSTIC LTD Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    258.80 -0.42 redarrow
    red-green-graph indicator
    16 Bearish
    0 Bullish
    • 5 Days 261.50
    • 26 Days 269.10
    • 10 Days 263.70
    • 50 Days 273.10
    • 12 Days 264.50
    • 100 Days 276.20
    • 20 Days 267.30
    • 200 Days 283.20
    261.58 PIVOT
    First Support 258.92 First Resistance 264.07 Second Support 256.43 Second Resistance 266.73 Third Support 253.77 Third Resistance 269.22
    RSI 39.51 ADX 14.97 MACD -4.51 Williams % R -82.04 Commodity Channel Index (CCI) -110.02
    Date 2026-07-15 Week 17811.00 Same Day 7270.00 Month 22071.00
    1 Year 0.52 3 Year 0.72
    Over 1 Month
    -2.55% down
    Over 1 Year
    -17.82% down
    Over 3 Months
    -6.65% down
    Over 3 Years
    0.00% down
    Over 6 Months
    -1.58% down
    Over 5 Years
    0.00% down

    SURAKSHA DIAGNOSTIC LTD Corporate Actions

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Suraksha Diagnostic Ltd?

    Answer Field

    Suraksha Diagnostic Ltd share price is for NSE ₹ 258.80 & for BSE ₹ 260.00 as on Jul 17 2026 02:00 PM.

    What is the Market Cap of Suraksha Diagnostic Ltd Share?

    Answer Field

    The market cap of Suraksha Diagnostic Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jul 17 2026 02:00 PM.

    What is the 52 Week High and Low of Suraksha Diagnostic Ltd?

    Answer Field

    The 52 Week High and Low of Suraksha Diagnostic Ltd for NSE is ₹ 333.00 and ₹ 224.10 and for BSE is ₹ 333.65 and ₹ 224.10.

    What is 1 year return for Suraksha Diagnostic Ltd?

    Answer Field

    The 1 year returns on the stock has been -19.89%.

    What is the P/E Ratio of Suraksha Diagnostic Ltd Share?

    Answer Field

    As on Jul 17 2026 02:00 PM the price-to-earnings (PE) ratio for Suraksha Diagnostic Ltd share is 39.76.

    What is the PB ratio of Suraksha Diagnostic Ltd Share?

    Answer Field

    As on Jul 17 2026 02:00 PM, the price-to-book (PB) ratio for Suraksha Diagnostic Ltd share is 47.96.

    How to Buy Suraksha Diagnostic Ltd Share?

    Answer Field

    You can trade in Suraksha Diagnostic Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Suraksha Diagnostic Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Suraksha Diagnostic Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Suraksha Diagnostic Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |